Raymond James Financial
EW icon

Raymond James Financial’s Edwards Lifesciences EW Stock Holding History

Raymond James Financial’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178M Buy
2,224,213
+86,904
+4% +$7.16M 0.05% 314
2025
Q4 		$182M Buy
2,137,309
+109,097
+5% +$8.95M 0.06% 294
2025
Q3 		$158M Sell
2,028,212
-52,660
-3% -$4.11M 0.05% 336
2025
Q2 		$163M Sell
2,080,872
-101,083
-5% -$7.54M 0.06% 309
2025
Q1 		$158M Sell
2,181,955
-706,653
-24% -$50.6M 0.06% 299
2024
Q4 		$214M Buy
+2,888,608
New +$202M 0.08% 223

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Raymond James Financial's EW Position: Q1 2026 in Review

Raymond James Financial increased its Edwards Lifesciences (EW) stake by 4.1% in Q1 2026, buying an estimated $7.16M and bringing the position to 2,224,213 shares worth $178M. The position accounts for 0.05% of the portfolio, ranked #314.

Raymond James Financial first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $214M in Q4 2024. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Raymond James Financial held 2,224,213 shares of Edwards Lifesciences worth $178M as of Q1 2026.
  • Raymond James Financial bought 86,904 Edwards Lifesciences shares in Q1 2026, an estimated $7.16M.
  • Edwards Lifesciences made up 0.05% of Raymond James Financial's portfolio in Q1 2026, its #314 holding.
  • Raymond James Financial first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Edwards Lifesciences position peaked at $214M in Q4 2024.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.